Asparagine utilization in Escherichia coli.
Asparagine-requiring auxotrophs of Escherichia coli K-12 that have an active cytoplasmic asparaginase do not conserve asparagine supplements for use in protein synthesis. Asparagine molecules entering the cell in excess of the pool required for use of this amino acid in protein synthesis are rapidly degraded rather than accumulated. Supplements are conserved when asparagine degradation is inhibited by the asparagine analogue 5-diazo-4-oxo-l-norvaline (DONV) or mutation to cytoplasmic asparaginase deficiency. A strain deficient in cytoplasmic asparaginase required approximately 260 mumol of asparagine for the synthesis of 1 g of cellular protein. The cytoplasmic asparaginase (asparaginase I) is required for growth of cells when asparagine is the nitrogen source. This enzyme has an apparent K(m) for l-asparagine of 3.5 mM, and asparaginase activity is competitively inhibited by DONV with an apparent K(i) of 2 mM. The analogue provides a time-dependent, irreversible inhibition of cytoplasmic asparaginase activity in the absence of asparagine.
D000641:Ammonia / Q000096:biosynthesis; D000693:Anaerobiosis; D001215:Asparaginase / Q000378:metabolism; D001216:Asparagine / Q000378:metabolism*; D001224:Aspartic Acid / Q000096:biosynthesis; D001391:Azo Compounds / Q000494:pharmacology; D001426:Bacterial Proteins / Q000096:biosynthesis; D002250:Carbon Radioisotopes; D002855:Chromatography, Thin Layer; D003470:Culture Media; D003593:Cytoplasm / Q000201:enzymology; D003720:Densitometry; D004926:Escherichia coli / Q000201:enzymology / Q000254:growth & development / Q000378:metabolism*; D005973:Glutamine / Q000378:metabolism; D009154:Mutation; D013237:Stereoisomerism; D014631:Valerates / Q000494:pharmacology
D001391:Azo Compounds; D001426:Bacterial Proteins; D002250:Carbon Radioisotopes; D003470:Culture Media; D014631:Valerates; D005973:Glutamine; D001224:Aspartic Acid; D001216:Asparagine; D000641:Ammonia; D001215:Asparaginase